FDA Approved: TRISENOX — Supplemental Application (Cephalon, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Trisenox (arsenic trioxide) submitted by Cephalon, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Promyelocytic Leukemia

Drugs mentioned

• Trisenox (arsenic trioxide)

Snippet

SUPPL AP for TRISENOX (ARSENIC TRIOXIDE)